Rapid Extensive Recurrence of Triple Negative Breast Cancer: Are Both Therapy and Cancer Biology the Culprit?

Triple negative breast cancer (TNBC) comprises 17-20% of all breast cancers and is one of the most common breast cancers. The lack of therapy and failure of existing therapy has been a challenge for clinicians. Doxorubicin (DOX) is the first-line therapy, however, it has significant limitations. Rap...

Descripción completa

Detalles Bibliográficos
Autores principales: Vyas, Dinesh, Deshpande, Kaivalya, Chaturvedi, Lakshmishankar, Gieric, Laput, Ching, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701073/
https://www.ncbi.nlm.nih.gov/pubmed/26767086
http://dx.doi.org/10.14740/jocmr2365w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701073/
https://www.ncbi.nlm.nih.gov/pubmed/26767086
http://dx.doi.org/10.14740/jocmr2365w

Ejemplares similares